| Tag |
First Indicator |
Second Indicator |
Subfields |
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
in00005772000 |
| 005 |
20260327174723.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
230812t20232023ne a ob 001 0 eng d |
| 040 |
|
|
|a YDX
|b eng
|e rda
|e pn
|c YDX
|d OPELS
|d UKMGB
|d UKAHL
|d SFB
|d OCLCF
|d MMU
|d OCLCO
|d SXB
|d OCLCO
|d OCLCQ
|d OCLCL
|
| 015 |
|
|
|a GBC3F5411
|2 bnb
|
| 016 |
7 |
|
|a 021176894
|2 Uk
|
| 020 |
|
|
|a 9780323958547
|q (electronic bk.)
|
| 020 |
|
|
|a 0323958540
|q (electronic bk.)
|
| 020 |
|
|
|z 9780323988186
|q (print)
|
| 020 |
|
|
|z 0323988180
|q (print)
|
| 035 |
|
|
|a (OCoLC)1393242383
|
| 037 |
|
|
|a 9780323958547
|b Ingram Content Group
|
| 050 |
|
4 |
|a RC376.5
|
| 060 |
|
4 |
|a WL 390
|
| 082 |
0 |
4 |
|a 616.8/3
|2 23/eng/20230823
|
| 049 |
|
|
|a TXAM
|
| 245 |
0 |
0 |
|a Motor system disorders.
|n Part I,
|p Normal physiology and function and neuromuscular disorders /
|c volume editor, David S. Younger.
|
| 246 |
3 |
0 |
|a Normal physiology and function and neuromuscular disorders
|
| 264 |
|
1 |
|a Amsterdam :
|b Elsevier,
|c [2023]
|
| 264 |
|
4 |
|c ©2023
|
| 300 |
|
|
|a 1 online resource (xviii, 808 pages) :
|b color illustrations
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Handbook of clinical neurology ;
|v v. 195
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
0 |
|
|a Description based on online resource; title from digital title page (ProQuest Ebook Central, viewed April 16, 2024).
|
| 505 |
0 |
|
|a Intro -- Motor System Disorders, Part I: Normal Physiology and Function and Neuromuscular Disorders -- Copyright -- Handbook of Clinical Neurology 3rd Series -- Foreword -- Preface -- Contributors -- Contents -- Section 1: Normal physiology and function -- Chapter 1: Skeletal muscle structure, physiology, and function -- Introduction -- Skeletal Muscle Structure -- Contractile Mechanisms -- Muscle Fiber Types -- Calcium Activation of Contraction -- Skeletal Muscle Function -- Neuromuscular Junction Structure and Development -- Neurotransmission -- Motor Unit Properties -- Motor Unit Recruitment -- References -- Chapter 2: Upper and lower motor neuron neurophysiology and motor control -- Introduction -- Functional Motor Systems in Brain and Spinal Cord -- Evolution of the Motor System -- Motor Cortex -- Organization and function -- Local circuitries of the primary motor cortex are layer and cell-type specific -- Sensory feedback -- Force and speed control -- Motor learning -- Motor program -- Mirror neuron system -- Spinal Cord -- Spinal descending motor pathways-Corticospinal tract -- Motor unit activity -- Spinal sensory input -- Local functions of the spinal cord -- Motor learning -- The Cerebellum -- The Lower Motor Neuron System -- Conclusion -- References -- Chapter 3: Vestibular motor control -- Overview -- Vestibular Motor Control: Neuronal Coding in Alert Animals -- Nonlinear & -- Spike Timing Codes: Implications for Motor Control and the Restoration of Function -- The Vestibulo-Ocular Reflex -- Adaptation and compensation of the VOR -- Vestibulospinal Reflex Pathways -- Adaptation and compensation of postural reflexes -- The Vestibular Cerebellum: Internal Models of Externally-Applied and Active Self-Motion -- Flocculus and ventral paraflocculus -- Anterior vermis (lobules I-V) -- Nodulus/uvula of the posterior cerebellar vermis.
|
| 505 |
8 |
|
|a Compensation and Extra-Vestibular Sensory Substitution in Central Pathways: Implications for Motor Control -- The unmasking of extra-vestibular information in early vestibular pathways -- Cerebellar-dependent mechanisms for vestibular motor compensation -- Voluntary Behavior: Steering, Reaching and Navigation -- Reaching -- Steering and navigation -- References -- Chapter 4: Autonomic failure: Clinicopathologic, physiologic, and genetic aspects -- Overview -- Historical background -- Components of the autonomic nervous system -- Sympathetic noradrenergic system -- Sympathetic cholinergic system -- Parasympathetic cholinergic system -- Sympathetic adrenergic system -- Parasympathetic and sympathetic outflow -- Sympathetic organization and output -- Parasympathetic organization and output -- Autonomic Control of Bladder, Bowel and Sexual Function -- Neuropathologic Characterization -- Sympathetic ganglia -- Parasympathetic ganglia -- The aging autonomic nervous system -- Baroreflexes, autonomic, and baroreceptor failure -- Neurodegenerative Autonomic Failure -- Involvement of central and peripheral autonomic components -- Consensus statement and definitions -- Orthostatic hypotension -- Pure autonomic failure -- Parkinson's disease with autonomic failure -- Multiple system atrophy -- Clinical and laboratory autonomic assessment -- Autonomic symptom assessment and disability -- Quantitative sudomotor axonal reflex test -- Thermoregulatory sweat test -- Head-up tilt table testing -- Heart rate response to deep breathing -- Valsalva maneuver -- Cardiac radioisotopic denervation imaging -- Supine and standing catecholamine levels -- Skin biopsy -- Electrodiagnostic studies -- Autonomic reflex screen and the composite autonomic score -- Multiple system atrophy -- Overview -- Pathophysiology -- Classification -- Autonomic failure.
|
| 505 |
8 |
|
|a Additional laboratory assessment -- Pure autonomic failure -- Historical turning points -- Diagnosis -- Selection for prospective cohort studies -- Laboratory studies -- Natural history and prognosis -- Parkinson's disease -- Overview -- Autonomic failure in PD -- Autonomic and neuropathological correlations -- Treatment and management of autonomic failure -- Orthostatic hypotension -- Gastrointestinal dysfunction -- Bladder, sexual and bowel dysfunction -- Hereditary Sensory and Autonomic Neuropathies -- Overview -- Familial dysautonomia -- Genetics -- Postmortem studies -- Sensory nervous system -- Autonomic nervous system -- Neurophysiology of autonomic failure -- Baroreflex failure autonomic storms -- Chemoreflex failure -- Prognosis -- Treatment of orthostatic hypotension -- Nonpharmacologic therapy -- Pharmacologic therapy -- Treatment of vomiting attacks and hypertensive crises -- Transient surges with everyday activities -- Vomiting attacks with autonomic crises -- Disease modifying therapy -- Small molecules -- Antisense oligonucleotides -- Autoimmune Autonomic Failure -- Background -- Illustrative case with antemortem and postmortem pathology -- Neurophysiology -- Serology -- Diagnosis and outcome -- Outcome and management -- Future Directions -- References -- Chapter 5: Gait control by the frontal lobe -- Introduction11Abbreviations used in the chapter are listed at the end of the chapter before References section. -- Frontal Lobe Control of Gait -- Fundamental framework of posture-gait control -- Cortical sensory-motor information processing -- Core Posture Gait Mechanisms in the Brainstem and Spinal Cord -- Locomotor regions -- Descending brainstem-spinal cord pathways -- Spinal locomotor network including the CPG -- Functional Neuroanatomy of the Cortical Control of Behavior Expression -- The prefrontal cortex.
|
| 505 |
8 |
|
|a Role of the prefrontal cortex in behavioral expression -- Slow walking and FOG by disturbances in the prefrontal cortex -- The premotor cortex -- Functional organization of the premotor cortex -- Role of the premotor-corticoreticular system in the posture-gait control -- Functional organization of corticofugal projections to the brainstem and spinal cord -- Possible Cortical Mechanisms of Human Posture-Gait Control -- Upright standing posture -- Gazing and orienting posture for attending to the target -- Anticipatory postural adjustment (APA) -- Initiating the first step -- Posture-Gait Control by the Cerebellum, BG, and Emotional Systems -- Cerebellar contribution to error detection -- Contribution of the BG and DA system in the posture-gait control and its automatization -- Involvement of emotional valence in freezing -- References -- Chapter 6: Parietal control of hand movement -- Introduction -- Parallel Visuomotor Processing -- Sensorimotor Apraxia -- Tactile apraxia -- Optic ataxia -- Localization -- Limb Apraxia -- Imitation deficits -- Localization -- Object use deficits -- Affordances -- Localization -- Executive Apraxia -- Localization -- Treatments -- Conclusion -- References -- Chapter 7: Immunology and microbiome: Implications for motor systems -- Introduction -- Immunology and Motor Systems -- Overview of the immune system -- The immune system in development & -- physiology -- The immune system in motor pathology -- The immune system in Parkinson disease and atypical parkinsonian syndromes -- The immune system in other basal ganglia-related movement disorders -- The immune system in cerebellar ataxias -- The immune system in amyotrophic lateral sclerosis -- The Microbiota-Gut-Brain Axis and Motor Systems -- The microbiota-gut-brain axis: Role in physiology and pathology of motor systems.
|
| 505 |
8 |
|
|a The microbiota-gut-brain axis in Parkinson disease -- The microbiota-gut-brain axis in Huntington disease -- The microbiota-gut-brain axis in amyotrophic lateral sclerosis -- The microbiota-gut-brain axis in nondegenerative ``network´´ movement disorders -- Conclusions -- Future Directions -- References -- Chapter 8: COVID-19 (novel SARS-CoV-2) neurological illness -- Background -- Epidemiology -- Zoonotic origin -- Animal models -- Disease definitions -- Susceptibility to Infection -- Acute COVID-19 Infection -- COVID-19 Diagnostic Testing -- Detecting viral RNA by RT-PCR -- Detecting antibodies to SARS-CoV-2 -- Rapid point of care strategies -- SARS-CoV-2 antigens: Comparison of rapid and standard tests -- Neurological Presentation -- Adults -- Children -- Cytokine Storm -- Clinicopathological Correlation -- Covid Variants -- Immunotherapy -- Hydroxychloroquine -- Remdesivir -- Monoclonal antibodies -- Bamlanivimab and etesevimab -- Casirivimab and imdevimab -- Sotrovimab -- Tixagevimab and cilgavimab -- Nirmatrelvir -- Corticosteroids -- Convalescent Plasma -- Intravenous immune globulin therapy -- Interleukin-6 inhibition -- Vaccination -- Chronic Covid Illness -- Long-Hauler and Long COVID -- Postacute sequela of SARS-CoV-2 (PASC) -- Neurodegeneration -- Alzheimer disease -- Parkinson disease -- Multiple sclerosis -- Neuropsychiatric illness -- Conclusion -- References -- Section 2: Clinical and laboratory diagnosis -- Chapter 9: Neurogenetic motor disorders -- Introduction -- Mitochondrial Genetics -- Clinical Clues of a Neurogenetic Motor Disorder -- Peripheral nervous system -- Central nervous system -- Hereditary cerebellar ataxias -- Genetic Neurological Disorders -- Muscular dystrophy -- Congenital myasthenic syndrome -- Presynaptic defects -- Synaptic space defects -- Postsynaptic defects -- Endplate development and maintenance defects.
|
| 650 |
|
0 |
|a Movement disorders.
|
| 650 |
|
2 |
|a Movement Disorders
|
| 650 |
|
2 |
|a Motor Skills
|x physiology
|
| 650 |
|
6 |
|a Troubles moteurs.
|
| 650 |
|
7 |
|a Movement disorders
|2 fast
|
| 655 |
|
7 |
|a Electronic books.
|2 local
|
| 700 |
1 |
|
|a Younger, David S.,
|e editor.
|1 https://id.oclc.org/worldcat/entity/E39PCjCCcjPxkgQrT8gxtkcGjK
|
| 710 |
2 |
|
|a ScienceDirect (Online service)
|
| 776 |
0 |
8 |
|i Print version:
|t Motor system disorders. Part 1. Normal physiology and function and neuromuscular disorders.
|d Cambridge, Mass.: Elsevier, 2023
|z 0323988180
|w (OCoLC)1372394222
|
| 830 |
|
0 |
|a Handbook of clinical neurology ;
|v v.195.
|
| 856 |
4 |
0 |
|u http://proxy.library.tamu.edu/login?url=https://www.sciencedirect.com/science/handbooks/00729752/195
|z Connect to the full text of this electronic book
|t 0
|
| 955 |
|
|
|a Elsevier ScienceDirect 2026-2027
|
| 994 |
|
|
|a 92
|b TXA
|
| 999 |
f |
f |
|i e80e9a5b-59b8-4624-8303-15bc6332b061
|s 1c8b77f4-bde3-4fab-b152-4a22edfd3bbf
|t 0
|
| 952 |
f |
f |
|a Texas A&M University
|b College Station
|c Electronic Resources
|s www_evans
|d Available Online
|t 0
|e RC376.5
|h Library of Congress classification
|
| 998 |
f |
f |
|a RC376.5
|t 0
|l Available Online
|